Seer, Inc. reported revenue of $4.0 million for the third quarter of 2022, compared to $2.2 million for the same period in 2021. The increase was primarily due to increased sales of the Proteograph Product Suite and its related products. The net loss for the quarter was $24.0 million, compared to $18.4 million for the corresponding prior year period. Cash, cash equivalents and investments were approximately $441.0 million as of September 30, 2022.
Revenue for Q3 2022 reached $4.0 million.
Gross profit for Q3 2022 was $1.9 million, with a gross margin of 49%.
Operating expenses for Q3 2022 totaled $27.0 million, including $9.1 million in stock-based compensation.
Net loss for Q3 2022 was $24.0 million.
Seer continues to expect full year 2022 revenue to be in the range of $14.0 million to $16.0 million.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance